Veterinary drug bioequivalence determination

Journal of Veterinary Pharmacology and Therapeutics

Volumn 20, Issue 2, 1997, Pages 79-90

  Toutain, P L ^a,c   Koritz, G D ^b  

^a UNIVERSITÉ DE TOULOUSE   (France)

^b UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^c NONE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BIOEQUIVALENCE; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG FORMULATION; METHODOLOGY; NONHUMAN; PHARMACODYNAMICS; PHARMACOKINETICS; PRIORITY JOURNAL; REVIEW; SCIENCE; STATISTICS; THEORY; VETERINARY MEDICINE;

EID: 0030901022     PISSN: 01407783     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2885.1997.00047.x     Document Type: Review

References (65)

1. Anderson, S. & Hauck, W.W. (1990) Consideration of individual bioequivalence. Journal of Pharmacokinetics and Biopharmaceutics. 18, 259-273.
2. Anonymous (1991) Commission of the European Community. CPMP Working Party of Efficacy of Medicinal Products. Note for guidance: Investigation of bioavailability and bioequivalence, III/54/89/1991. En-final.
3. Anonymous (1994) Conduct of bioequivalence studies in animals. In The Rules Governing Medicinal Products in the European Union. Vol. 7, Guidelines for the testing of veterinary medicinal products. European Commission, pp. 37-46.
4. Anonymous (1996) Bioequivalence Guideline. Center for Veterinary Medicine. Food and Drug Administration, pp. 1-26. Roekville, MD.
5. Baggot, J.D. (1992) Bioavailability and bioequivalence of veterinary drug dosage forms with particular reference to horses: an overview. Journal of Veterinary Pharmacology and Therapeutics, 15, 160 173.
6. Balant, L.P. & Gex-Fabry. M. (1994) Dealing with variability during drug development, Journal of Pharmacy and Pharmacology, 46 (suppl. 1). 439-444.
7. Blume, H., Zhong, D., Elze, M., Wendt, G., Schug, B., Scheidel, B., Hutt, H.J. & Hagenloccher, M. (1994) Advantage of a steady-state crossover design in assessment of bioequivalence of highly variable drugs: propafone. European Journal of Pharmaceutical Sciences, 2, 385-393.
8. Blume H., McGilveray, I. J. & Midha, K.K. (1995) Bio-international 94 conference on bioavailability, bioequivalence and pharmacokinetic studies and pre-conference satellite on 'in vivo/in vitro correlation'. European Journal of Drug Metabolism and Pharmacokinetics. 20, 3-13.
9. Bouvier d'Yvoire, M., Coquerel, A., Chretien, P. & Tremblay, D. (1993) Pooling plasmas for a rapid answer in pharmacokinetic studies: application to a bioequivalence study of hydrocortisone tablets. Fundamental Clinical Pharmacology. 7, 253-260.
10. Chen, M.I., & Jackson, A.J. (1991) The role of metabolites in bioequivalency assessment. I. Linear pharmacokinetics without first-pass effect. Pharmaceutical Research. 8, 25-32.
11. D'Argenio, D.Z. (1981) Optimal sampling times for pharmacokinetic experiments. Journal of Pharmacokinetics and Biopharmaceutics. 6, 739-759.
12. D'Argenio, D.Z. & Katz, D. (1983) Sampling strategies for noncompartmental estimation of mean residence time. Journal of Pharmacokinetics and Biopharmaceutics. 4, 435-446.
13. Diletti, E., Hauschke, D. & Steinijans, V.W. (1991) Sample size determination for bioequivalence assessment by means of confidence intervals. International Journal of Clinical Pharmacology. Therapy and Toxicology, 29, 1-8.
14. Diletti, E., Hauschke, D. & Steinijans, V.W. (1992) Sample size determination: Extended tables for the multiplicative model and bioequivalence ranges of 0.9 to 1.11 and 0.7 to 1.43. International Journal of Clinical Pharmacology, Therapy and Toxicology, 30, (suppl. 1) 59-62.
15. Dixon, W.I. (1953) Processing data for outliers. Biometrics, 9, 74-89.
16. Dressman, J.B. (1986) Comparison of canine and human gastrointestinal physiology. Pharmaceutical Research, 3, 123-131.
17. Ekbohm, G. & Melander, H. (1989) The subject-by-formulation interaction as a criterion of interchangeability of drug. Biometrics, 45, 1249-1254.
18. max for absorption rates in investigations of bioequivalence. International Journal of Clinical Pharmacology, Therapy and Toxicology, 29, 394-399.
19. Endrenyi, L. & Schulz, M. (1993) Individual variation and the acceptance of average bioequivalence. Drug Information Journal, 27, 195-201.
20. max/AUC in investigations of bioequivalence. International Journal of Clinical Pharmacology, Therapy and Toxicology, 31, 184-189.
21. Gaus, W. & Högel, J. (1992) Balanced designs for multiple crossover studies. Drug Research, 42, 163-172.
22. Grizzle, J.E. (1965) The two-period change-over design and its use in clinical trials. Biometrics, 21, 467-480.
23. Hauschke, D., Steinijans, V.W. & Diletti, E. (1990) A distribution-free procedure for the statistical analysis of bioequivalence studies. International Journal of Clinical Pharmacology, Therapy and Toxicology, 28, 72-78.
24. Hauschke, D., Steinijans, V.W., Diletti, E. & Burke, M. (1992) Sample size determination for bioequivalence assessment using a multiplicative model. Journal of Pharmacokinetics and Biopharmaceutics, 20, 557-561.
25. Jamalil, F. (1992) Stereochemistry and bioequivalence. Journal of Clinical Pharmacology, 32, 930-934.
26. Jones, B. & Kenward, M.G. (1989) Design and analysis of cross-over trials. Chapman & Hall Ed., 340 p.
27. Kaniwa, N., Ogata, H., Aoyagi, N., Takeda, Y. & Uchiyama, M. (1989) Power analyses of moment analysis parameter in bioequivalence tests. Journal of Pharmaceutical Sciences, 78, 1020-1024.
28. Koritz, G.D. (1980) Bioequivalence of drug products. Journal of the American Veterinary Medical Association, 177, 279-281.
29. Koritz, G.D. (1994) Human food safety: Human food safety considerations. Journal of Veterinary Pharmacology and Therapeutics, 17, 113-115.
30. Lacey, L.F., Keene, O.N., Duquesnoy, C. & Bye, A. (1994) Evaluation of different indirect measures of rate of drug absorption in comparative pharmacokinetic studies. Journal of Pharmaceutical Sciences, 83, 212-215.
31. Liu, J.P. & Chow, S.C. (1992) Sample size determination for the two one-sided tests procedure in bioequivalence. Journal of Pharmacokinetics and Biopharmaceutics, 20, 101-104.
32. MacGilveray, I.J., Midha, K.K., Skelly, J.P., Dighe, S., Doluisio, J.T., French, I.W., Karim, A. & Burford, R. (1990) Consensus report from "Bio International '89": issues in the evaluation of bioavailability data. Journal of Pharmaceutical Sciences, 79, 945-946.
33. Makuch, R. & Johnson, M. (1989) Issues and planning and interpreting active control equivalence studies. Journal of Clinical Epidemiology, 42, 503-511.
34. 0-inf). Pharmaceutical Research, 8, 512-517.
35. Martinez, M.N. & Riviere, J.E. (1994) Review of the 1993 Veterinary Drug Bioequivalence Workshop. Journal of Veterinary Pharmacology and Therapeutics, 17, 85-119.
36. Marzo, A. & Balant, L.P. (1995) Bioequivalence - an updated reappraisal addressed to applications of interchangeable multi-source pharmaceutical products. Drug Research, 45, 109-115.
37. Metzler, C.M. (1989) Bioavailability/Bioequivalence: Study Design and Statistical Issues. Journal of Clinical Pharmacology, 29, 289-292.
38. Midha, K.K., Hubbard, J.W., Rawson, M. & Gavalas, L. (1994) The application of partial areas in assessment of rate and extent of absorption in bioequivalence studies of conventional release products: experimental evidence. Evidence Journal of Pharmaceutical Sciences, 2, 351-363.
39. Murray, M.J. & Schusser, G.F. (1993) Measurement of 24-h gastric pH using an indwelling pH electrode in horses unfed, fed and treated with ranitidine. Equine Veterinary Journal, 25, 417-421.
40. Nowakowski, M.A., Lynch, M.J., Smith, D.G., Logan, N.B., Mouzin, D.E., Lukaszewicz, J., Ryan, N.I., Hunter, R.P. & Jones, T.M. (1995) Pharmacokinetics and bioequivalence of parenterally administered doramectin in cattle. Journal of Veterinary Pharmacology and Therapeutics, 18, 290-298.
41. Nevius, A.B., Chinchilli, V.M., Metzler, C.M., Powers, J.D., Schuirmann, D.J. & Silverberg, A.R. (1994) Panel consensus report: statistical issues, Review of the 1993 Veterinary Drug Bioequivalence Workshop. Journal of Veterinary Pharmacology and Therapeutics, 17, 111-113.
42. Oosterhuis, B. & Jonkman, J.H.G. (1993) Advantages and disadvantages of reformulation of older drugs. Clinical Pharmacokinetics, 25, 165-171.
43. Phillips, K.F. (1990) Power of two one-sided tests procedure in bioequivalence. Journal of Pharmacokinetics and Biopharmaceutics, 18, 137-144.
44. Pidgen, A.W. (1992) Statistical aspects of bioequivalence - a review. Xenobiotica, 22, 881-893.
45. Pope, D.G. (1984) Physico-chemical and formulation-induced veterinary drug product bioinequivalences. Journal of Veterinary Pharmacology and Therapeutics, 7, 85-112.
46. Read, N.W. & Sugden, K. (1987) Gastrointestinal dynamics and pharmacology for the optimum design of controlled-release oral dosage forms. Critical Reviews in Therapeutic Drug Carrier Systems. 3, 221-262.
47. Schall, R. & Luus, H.G. (1992) Comparison of absorption rates in bioequivalence studies of immediate release drug formulations. International Journal of Clinical Pharmacology, Therapy and Toxicology, 30, 153-159.
48. Schall, R., Luus, H.G., Steinijans, V.W. & Hauschke, D. (1994) Choice of characteristics and their bioequivalence ranges for the comparison of absorption rates of immediate release drug formulations. International Journal of Clinical Pharmacology, Therapy and Toxicology, 32, 323-328.
49. Schuirmann, D.J. (1987) A comparison of two-one-sided tests procedure and the power approach for assessing the equivalence of average bioavailability. Journal of Pharmacokinetics and Biopharmaceutics, 15, 657-680.
50. Schuirmann, D.J. (1990) Design of bioavailability, bioequivalence studies, Drug Information Journal, 24, 315-323.
51. Shah, V.P., Midha, K.K., Dighe, S., McGilveray, I.J., Skelly, J.P., Yacobi, A., Layloff, T., Viswanathan, C.T., Cook, C.E., McDowall, R.D., Pittman, K.A. & Spector, S. (1992) Analytical methods validation: bioavailability and pharmacokinetic studies. Journal of Pharmaceutical Sciences, 81, 309-312.
52. Sheiner, L.B. (1992) Bioequivalence revisited. Statistics in Medicine, 11, 1777-1788.
53. Skelly, J.P., Van Buskirk, G.A., Savello, D.R., Amidon, G.L., Arbit, H.M., Dighe, S., Fawzi, M.B., Malick, A.W., Malinowski, H., Nedich, R., Peck, G.E., Shah, V., Shangraw, R.F., Schwartz, J.B., Truelove, J. (1992) Workshop report: scale-up of immediate release oral solid dosage forms. European Journal of Pharmacology and Biopharmacy, 38, 213-216.
54. Steinijans, V.W., Sauter, R., Jonkman, J.H.G., Schulz, H.U., Stricker, H. & Blume, H. (1989) Bioequivalence studies: single vs. multiple dose. International Journal of Clinical Pharmacology, Therapy and Toxicology, 27, 261-266.
55. Steinijans, V.W. & Hauschke, D. (1990) Update on the statistical analysis of bioequivalence studies. International Journal of Clinical Pharmacology. Therapy and Toxicology, 28, 105-110.
56. Steinijans, V.W., Hauschke, D. & Jonkman, J.H.G. (1992) Controversies in bioequivalence studies. Clinical Pharmacokinetics, 22, 247-253.
57. Steinijans, V.W. & Hauschke, D. (1993) International harmonization of regulatory bioequivalence requirements. Clinical Research and Regulatory Affairs, 10, 203-220.
58. Steinijans, V.W. & Schulz, H.U. (1992) Bioequivalence Assessment: Methods and Applications, International Journal of Clinical Pharmacology Therapy and Toxicology, 30, (Suppl. 1) 1-68.
59. Sundlof, S.F., Brown, S.A., Nevius, A.B., Powers, T.E. & Toutain, P.L. (1994) Panel consensus report: protocol development. Review of the 1993 Veterinary Drug Bioequivalence Workshop. Journal of Veterinary Pharmacology and Therapeutics, 17, 100-102.
60. max/AUC is the effective metric in investigation of bioequivalence. Pharmacological Research, 6, 937-942.
61. Urso, R. & Aarons, L. (1983) Bioavailability of drugs with long elimination half-lives. European Journal of Clinical Pharmacology. 25, 689-695.
62. Watson, A.D.J. (1992) Bioavailability and bioinequivalence of drug formulations in small animals. Journal of Veterinary Pharmacology and Therapeutics, 15, 151-159.
63. Wijnand, H.P. (1992) The determination of the absolute bioavailability for drug substances with long elimination half-lives (with PC-programs for the method of truncated areas). Computer Methods and Programs in Biomedicine, 39, 61-73.
64. Wijnand, H.P. (1993) Bioequivalence revisited: non-parametric analysis of two-period cross-over studies. Computer Methods and Programs in Biomedicine, 40, 249-259.
65. Westlake, W.J. (1981) Response to T.B.L. Kirkwood: bioequivalence testing. A need to rethink, Biometrics, 37, 589-594.